In the present report, we have investigated the in vitro differentiation of surface(s) slgD + and slgD-human B cells into Ig-secreting calls in response to various stimuli, slgD + B cells homogeneously expressed some of the antigens identifying mantle zone B cells, but lacked expression of germinal center markers, thus confirming that the B cell populations positively selected on the basis of slgD expression were highly enriched for naive B lymphocytes. Conversely, slgD-B cells expressed some of the antigens spedfically associated with germinal center B cells. T cell-independent differentiation of slgD + and sIgD-B cells could be achieved by simultaneous crosslinking of sIgs and CD40 in the presence of a mouse Ltk-cell line stably expressing human CDw32/Fc'yPdI (CDw32 L cells). In this experimental system, sIgD + B cells were exclusively proned for IgM synthesis, whereas sIgD-B ceils produced IgG, IgM, and IgA. Both the human and viral forms of interleukin 10 (ILd0) strongly increased the Ig secretion by sIgD + and slgD-B cells simultaneously activated through slgs and CD40. IgM and IgG constituted the predominant Ig isotype produced by slgD + and slgD-B cells, respectively, in response to IL-10. slgD + B cells could be induced for IgA synthesis upon co-culturing with transforming growth factor (TGF-~) and II.-10, in the presence of an anti-CD40 monodonal antibody presented by the CDw32 L cells. In contrast, TGF-~ suppressed the IL-10-mediated IgG, IgM, and IgA secretions by slgD-B cells, slgD + B cells could not be induced for IgA synthesis by TGF-~ and Ibl0 after crosslinking of their slgs, suggesting that ligation of CD40 was one of the obligatory signals required for commitment of naive B cells to IgA secretion. Limiting dilution experiments indicated that the IgA-potentiating effect of TGF-B was due to its capacity to increase the frequency of IgA-producing cells, most likely as a consequence of class switching. Taken together, our data strongly suggest that TGF-B is involved in the regulation of IgA isotype selection in humans.
T he pattern of Ig classes secreted by B cells in response to antigenic stimulation depends upon several factors such as the structure of the antigen and the anatomic site in which the immune response takes place. The production of high affinity antibodies using downstream heavy chain genes, in the course of a secondary immune response, results from a maturation process initiated by the antigen itself, which occurs within the germinal centers of secondary follicles (1, 2) . As recently demonstrated in the murine system (3, 4) , the molecular mechanism of class switching involves the rearrangement of the genes located on the heavy chain locus and the subsequent deletion of the C. genes intervening between a variable region exon and the C. gene to be expressed. Evidence supports the notion that this process is directed and regulated by cytokines and other environmental signals delivered to B cells through interactions with other cell types. In mice, Ib4 has been described to regulate the secretion of IgE and IgG1, whereas IFN-'g and TGF-~ have been associated with the induction of IgG2a and IgA synthesis, respectively (5, 6) . In humans, it is now recognized that IL-4 is involved in IgE (7, 8) and IgG4 (9, 10) heavy chain switching, but to this date, the cytokine-mediated regulation of IgG1, IgG2, IgG3, and IgA isotypes has not been elucidated. The relative lack of information on that matter in the human system may partly relate to differences in the experimental models used in mice and in humans. Indeed, murine studies have essentially relied on the use of LPS to initiate responsiveness of B cells to switch factors, whereas such a tool was not available for human B cells until recently. Consequently, the study of the cytokine regulation of Ig isotype switching in humans has long been hampered by the relatively poor efficiency of the activation systems, precluding the culture of B cells in limiting dilutions. In addition, the maturational state of the B cell populations studied in early experiments was poorly defined and did not allow discrimination between isotype switching and maturation of pre-committed precursors.
However, two novel experimental systems in which highly efficient activation of human B ceils could be achieved through triggering of non-Ig-related molecules have permitted us to overcome these technical difficulties. The first one is based on the capacity of syngeneic or allogeneic activated T cells to stimulate entry of B cells into cycle in a non-MHC-restricted fashion via direct cell-to-cell contact (11) (12) (13) (14) . In the second one, polyclonal activation and sustained proliferation of human B cells is obtained by presentation of an anti-CD40 mAb on irradiated mouse L cells stably expressing CDw32/ Fcq/glI (15) . In both models, B calls can be induced for IgE synthesis after Ib4 stimulation (10, 16) . The observation that Ib4 is not able to drive purified human B cells to differentiate into IgE-secreting cells unless T cells (10) , EBV (17) or an anti-CD40 mAb (16, 18, 19) are provided, is consistent with the hypothesis that Ig isotype switching to IgE requires at least two signals, one ddivered by IIr the other mediated through CD40 or another B cell surface structure. Therefore, we explored the possibility that the CD40 signaling pathway could also be involved in the control of IgG and IgA isotype selection. We based our experimental approach on the assumption that naive B cells positively sdected on the basis of sIgD expression and presumably depleted in postswitch B cells could constitute a suitable target for the detection of switch events. Isolated sIgD + and sIgD-B cells were first compared for their capacity to secrete Ig in response to various B cell stimulants. In the absence of exogenous factors, both B cell subsets were inducible for Ig secretion after costimulation with anti-Ig reagents and an anti-CD40 mAb presented on CDw32 L cells, sIgD + B cells produced IgM exclusively, whereas slgD-B cells produced IgM, IgG, and IgA, with a predominance of IgG.
Both human Ibl0 and the EBV-encoded protein BCRF-11 (or viral II.,10), presenting an extensive homology with the human molecule (20, 21) , strongly enhanced the Ig response elicited in both B cell subsets by dual ligation of sIgs and CD40. Furthermore, addition of TGF-B together with ILl0 and crosslinked anti-CD40 antibodies resulted in a selective induction of IgA secretion from sIgD + B cells, but strongly suppressed the IL-10-mediated production of IgG, IgM, and IgA in the sIgD-B cell subset. The implications of these findings on the possible role of CD40 and TGF-B in the control of IgA isotype selection are discussed.
Materiah and Methods
Reagents. Insolubilized anti-IgM antibodies were purchased from Bio-Rad Laboratories (Richmond, CA) and were used at 5
1 Abbreviations used in this paper: BCRF-1, Epstein-Barr virus BamHI C fragment, rightward reading flame 1; SAC, staphylococcus aureus strain Cowan I.
/~g/ml. Formalinized particles ofStaphflococcus aureus strain Cowan I (SAC) were purchased as Pansorbin from Calbiochem-Behring Corp. (San Diego, CA) and were used at the final concentration of 0.005% (vol/vol). FITC-conjugated streptavidin was purchased from Immunotech (Luminy, France).
Antibodies. The monoclonal and polyclonal antibodies used for phenotypic and functional studies were obtained from the following sources: PE-conjugated anti-CD2 (Leu 5), anti-CD3 (Leu 4), anti-CD20 (Leu 16) mAbs and unconjugated anti-CD10, anti-CD14 (Leu M3), and anti-IgM mAbs (Becton Dickinson & Co., Mountain View, CA); anti-CD38 mAb (Ortho Pharmaceutical, Raritan, NJ); anti-CD2 and anti-CD3 mAbs used for negative selection of B cells with magnetic beads (Aster Laboratories, La Gaude, France); biotinylated, goat anti-human IgD antibodies (Amersham International, Amersham, Bucks, UK); PE-conjugated F(ab')2 fragments of sheep anti-mouse IgG and IgM antibodies used for indirect irnmunofluorescence stainings (AMD; Eurobio, Paris, France).
The anti-CD23/FceRII mAb 25 was prepared in the laboratory as previously described (22) . The UCL-3D3 mAb specifically recognizing mantle zone B cells (23) and the anti-CD44 mAb NKI-Pl (gp 90, Pgp-1, H-CAM) were kindly provided by Dr. P. Beverley (Courtauld Institute, London, UK) and Dr. S. T. Pals (Free University, Amsterdam, The Netherlands), respectively. The anti-CD40 mAb 89 was produced in the laboratory (24) and was used at a final concentration of 0.5/~g/ml throughout the study.
Factors. Each of the cytokines listed below was tested at various doses chosen above and below the optimal concentration point determined in spedfic bioassays as described in detail previously (16) . For the sake of clarity, only the optimal concentration value is mentioned here. Except where indicated, all cytokines were under the form of purified recombinant material. IL-lce (10 s U/mg), IL6 (107 U/rag), and TNF-c~ (2 x 107 U/mg) were purchased from Genzyme Corp. (Cambridge, MA). They were routinely used at 100 U/ml, 5 ng/ml, and 25 ng/ml, respectively. Ib2 (3 x 106 U/mg) and IFN-'Ir (107 U/rag) were purchased from Amgen Biologicals (Thousand Oaks, CA) and were routinely used at 20 U/ml and 500 U/ml. IL-3 (5 x 10 + U/mg) and IL-4 (107 U/mg) were kindly provided by Drs. S. Tindall and P. Trotta (Schering-Plough Research, Bloomfidd, NJ). They were used at 10 ng/ml and 500 U/ml, respectively. IbS, semi-purified by afhnity column chromatography from culture supernatants of Cos 7 cells transfected with the IL-5 cDNA clone, was kindly provided by Dr. R. Coffman (DNAX, Palo Alto, CA). It was usually tested at 15 ng/ml. IL-7 (provided by Dr. F. Lee, DNAX) was used as a 5% dilution (,~15 U/ml) of a culture supematant of Cos 7 cells transfected with the human IL-7 cDNA done. TGF-31 (R and D Systems Inc., Minneapolis, MN) was usually tested at 0.6 ng/ml, except where indicated. The EBV-encoded protein BCRF1/viral Ibl0 (rib10) and human Ibl0 (hlbl0) were used as culture supernatants of Cos 7 cells transfected with the vIL-10 or hIL-10 cDNA clones. In some experiments, highly purified Escherichia coli-derived rvlbl0 (5 x 10 s U/mg) (kindly provided by Dr. R. Kastelein, DNAX) was used at a concentration of 500 ng/ml.
Isolation of slgD § and slgD-B Cell Populat~ns. Tonsillar mononuclear cells were separated by standard Ficoll/I-Iypaque gradient method and were next submitted to E rosetting with SRBC. Nonrosetting ceils (E-fraction) were labded with anti-T cell (anti-CD2 and anti-CD3 mAbs) and antimonocyte (anti-CD14 mAb) mAbs, and subsequently incubated twice with magnetic beads coated with anti-mouse IgG antibodies (Dynal, Oslo, Norway). Residual non-B cells were removed by applying a magnetic field for 10 rain. The purity of the B cell populations obtained after this procedure was greater than 95% as estimated by FACScan | immunofluorescence stainings performed with anti-CD19, CD20, CD2, CD3, and CD14 mAbs. Isolation of sIgD + and slgD-B cell populations was performed using a preparative magnetic cell separation system (MACS| Becton-Dickinson & Co.) according to the experimental procedure described in detail by Miltenyi et al. (25) . Briefly, unfractionated tonsil B cells resuspended in PBS plus 1% BSA plus 0.01% sodium azide plus 5 mM EDTA, were labded by sequential incubation with biotinylated goat anti-human IgD antibodies (Amersham International) and FITC-conjugated streptavidin (Immunotech, Luminy, France). After washings in PBS plus sodium azide plus EDTA, B cells were resuspended at 2 x 108 cells/ml in the same buffer and incubated with super paramagnetic beads (5 #1 of the solution provided by the manufacturers for 108 cells) conjugated to biotin. Cells were next deposited on specially designed columns and separated into positive and negative populations using a high-gradient magnetic field. Unlabeled sIgD-B cells were duted from the column while the magnetic field was applied and slgD + B cells labeled with magnetic beads were next recovered by vigorous washing of the column matrix after its removal from the magnet. Purity of both populations was directly assessed by fluorescence analysis on a FACScan | since the positive cells were stained by the complex biotin-anti-IgD/FITCstreptavidin/biotin-magnetic beads.
B Cell Cultures.
All cultures were performed in Iscove's medium enriched with 50 #g/ml human transferrin, 5 #g/ml bovine insulin, 0.5% BSA, 5 x 10 -5 M2-/3 MF. (all from Sigma Chemical Co., St. Louis, MO) and 5% heat-inactivated FCS (Flow Laboratories, Irvine, CA). All B cell cultures were performed in presence of irradiated (7,000 rad) CDw32/FcTKII-transfected Ltk-cells (CDw32 L cells), kindly provided by Dr. K. Moore (DNAX), according to the experimental procedure described previously (15, 16) . In most experiments, B cells were seeded in round-bottomed microtiter trays at a density of 5 x 104 cells per well under a final volume of 200 t~l, for a culture period of 10 d. Cytokines, polyclonal B cell activators (SAC, insolubilized anti-IgM antibodies, and the anti-CD40 mAb 89), and irradiated CDw32 L cells (5 x 10Uwell) were added at the onset of the culture. IgM, IgG, IgA, and IgE levels were measured in culture supematants by standard ELISA techniques as described elsewhere (26, 27) . Each culture point was performed in quadruplicate. Wells in which the OD value was at least four times higher than background levels were considered positive. Calculations to determine the frequency of IgAsecreting cells were carried out according to Taswell (28) . The frequency of negative responses at each input number of B cells was used to construct a plot of the log10 of the number of negative cultures versus the number of cultured B cells. The frequency of B cells able to secrete IgA was calculated from the 37% intercept of the regression line, according to the Poisson distribution. The goodness of fit of the regression line was tested using the X z test. In all experiments performed, the results obtained were compatible with the hypothesis of a single hit event, suggesting that we were dealing with a single ceU type dilution.
Limiting Dilution Cultures and

Results
slgD § B Cells Display the Phenotypic Features of Mantle Zone B Cells.
The phenotype of the sIgD + and sIgDpopulations recovered after magnetic separation was examined using mAbs directed against surface molecules sdectivdy distributed on mantle zone B cells, such as slgM (29) , CD23 (30) , and UCL 3D3 (23), or on germinal center B ceils, such as CD10 or CD38 (31) . Expression of other antigens, such as CD20 and CD44, which have been reported to display different staining intensities in mantle zone and germinal centers (31, 32) , was also assessed on both B cell fractions. As shown in Fig. 1 , the fluorescence peak obtained with slgD in the positive population was monotonal and dearly separated from the control, indicating the virtual absence of sIgD-B call contaminants in the positive fraction. Conversely, slgD + B cells were consistently undetectable in the negative popuhtion even after 48 h of culture (data not shown), therefore excluding underestimation of sIgD + 13 ceil conruminants possibly due to internalization of sIgD as a consequence of the isolation procedure. All slgD + B cells were homogeneously positive for slgM, CD23, UCL 3D3, and CD44 expression, weakly stained with the anti-CD38 mAb, and lacked CD10. In contrast, slgD-B cells did not bind the anti-CD23 and UCL 3D3 antibodies and weakly expressed sIgM as estimated by the low percentages of positive ceils (17 +_ 8%, mean + SD of three experiments) and by the low intensity of staining. CD10 and CD38 were distributed on 50 _+ 10% and 36 _+ 10% (mean +_ SD of three experiments) of the sIgD-B ceils, respectively. CD20 was uniformly expressed on all sIgD + B ceils, but the levels of expression of this antigen differentiated three subsets within the sIgD-compartment: a minor negative population, a dimly stained population, and a brightly stained population. Similarly, three intensities of expression of CD44 were observed on sIgD-B calls, thus dividing this population in CD44 hish, CD44 l~ and CD44-subsets. Taken together, these results indicate that B calls positively selected on the basis of slgD expression are phenotypically related to mantle zone B ceils, whereas sIgD-B cells constitute a heterogeneous population including a subset of cells displaying some of the distinctive phenotypic features of geiu~inal center B cells. were measured in 10-d culture supernatants by ELISA. As illustrated in Table 1 , neither anti-Ig reagents nor crosslinked anti-CD40 mAb could stimulate Ig synthesis from sIgD + B cells. However, when sIgs and CD40 were simultaneously crosslinked (SAC plus anti-CD40 or anti-IgM plus anti-CD40), sIgD + B cells were induced to secrete high amounts of Igs. The levels of Igs secreted by sIgD + after costimulation with SAC and crosslinked anti-CD40 antibodies reached, on average, 40 times the amount of Igs produced in response to each of those B cell stimulants used alone (as estimated in 10 separate experiments). The Ig response of sIgD + B ceils under these culture conditions was exclusively restricted to the IgM isotype. However, the levels of IgM secreted by sIgD § B cells in response to SAC and anti-CD40 were 10-20-fold higher than those induced by the combination of anti-IgM and anti-CD40 antibodies. Similarly, in the absence of exogenous factors, slgD-B cells were induced for Ig synthesis when sIgs and CD40 were concomitantly triggered by SAC and anti-CD40 mAb (Table 2) . However, the pattern of Ig isotypes produced by slgD-B cells in this activation system was strikingly different from that of sIgD + B cells, since both IgM and IgG were secreted in large amounts. IgG was reproducibly found to be the major isotype induced and constituted on average 76 _+ 11% of the overall Ig production (mean + SD of seven experiments) in these experimental conditions. IgA secretion varied from one tonsil sample to another but usually remained a minor component of the Ig response elicited by SAC and anti-CD40 from slgD-B cells. IgE levels always remained below the threshold of detection whatever the cell population examined. In contrast to slgD + B cells, slgD-B cells produced minor amounts of Igs upon costimulation with anti-IgM and anti-CD40 antibodies, a result consistent with the low expression of slgM on this population.
T Cell-independent Differentiation of B cells after Dual
Activated slgD + and slgD-B Cells Produce Large Amounts of lgs in Response to I1.,10.
We next examined the capacity of various cytokines to modulate the Ig response dicited by SAC and anti-CD40 from sIgD + and sIgD-B cells. Several recombinant factors including Ibl-7, TNF-c~, TGF-/~ and IFN-3' repeatedly failed to enhance Ig synthesis from sIgD + B cells, activated through concomitant triggering of surface Igs and CD40 antigen (data not shown). In contrast, human and viral I1:10 dramatically increased the IgM production elicited by the combination of SAC and mAb 89 from slgD + B cells (Table 3 and Fig. 2, top) . IgG and IgA were also produced, but they remained a minor component of the Ig response stimulated by Ibl0 from slgD + B cells since the levels of production of these isotypes constituted, on average, 1.4 _+ 0.7% and 0.5 _+ 0.2% (mean + SD of 10 experiments) of the overall Ig synthesis, respectively. I1:10 also synergized with SAC and crosslinked anti-CD40 to stimulate IgM, IgG, and IgA production from slgD-B cells (Table   3 and Fig. 2, bottom) . In contrast to slgD + B cells, IgG was the predominant isotype secreted by slgD-B cells in response to I1:10 since it accounted, on average, for 68 _+ 13% (mean _+ SD of 10 experiments) of the overall Ig synthesis, whereas IgM and IgA accounted for 19.5 + 15% and 12.5 _+ 12%, respectively. IgE synthesis was not enhanced above background levels (150 pg/ml) by I1:10 whatever the B cell population considered. The stimulatory effects of I1:10 on IgM, IgG, and IgA synthesis on both populations were confirmed with purified recombinant material (Table 4 ), indicating that the enhancing effect of I1:10 on Ig synthesis is an innate property of the molecule. I1:10 failed to stimu- Representative of seven experiments. Same culture conditions as in Table 3 . Ig levels represent the mean + SD of quadruplicate determinations. Purified viral IL-10 was used at 500 ng/ml. * < 0.08/~g/ml. 
TGF-[3 Specifically Enhances IgA Synthesis from slgD § B Cells
It is striking that the
Discussion
Naive B cells that coexpress sIgM and sIgD migrate from the bone marrow to the periphery and form the primary follicles in secondary lymphoid organs. After antigen stimulation, primary follicles develop into secondary follicles schematically composed of two major microanatomical structures: the mantle zone in which slgM+/slgD + naive B ceUs are located, and the germinal center in which the antigendependent maturation process occurs (34) . Here, we have attempted to isolate naive B cells by the means of anti-IgD antibodies to build up a reliable experimental model that could be used to study the cytokine regulation of isotype switching to IgG and IgA. This technical approach was supported by the fact that IgG-and IgA-committed precursors reside within the sIgD-B cell subset (35, 36) . The results of the phenotypic and functional analysis of sIgD + B calls both confirmed that our separation criteria allowed isolation of naive B cells. First, sIgD + B cells homogeneously expressed a panel of markers identifying mantle zone B cells and virtually lacked expression of CD10 and CD38, which are distributed on certain germinal center B calls. Second, sIgD + B cells costimulated with SAC and an anti-CD40 mAb presented on CDw32 L cells displayed a pattern of isotype secretion exclusively restricted to IgM. The heterogeneity of the sIgD-B cell subset, suggested by the complex distribution of CD10, CD20, and CD44, could reflect the diver- sity of the stages of B cell maturation (centrocytes versus centroblasts, for instance) found within the germinal center. Yet, considering that a few slgD-B cells also lacked CD20 (Fig. 1) , expression of which is lost at the plasma cell stage (37) , it is probable that a minor population of extra-follicular B cells, such as plasmablasts, is also included within this B cell compartment.
Ligation of slgs and CD40 can promote B cell proliferation in combination with other stimuli (38, 39) , or can directly induce entry of B cells into cycle when the anti-Ig (40) or anti-CD40 antibodies (15) are presented under an immobilized form. However, our data indicate that T cell-independent maturation of human B cells can be achieved, in the absence of exogenous factors, by the combination of Igcrosslinking agents and immobilized anti-CD40 antibodies. In this respect, this particular mode of activation of human B cells presents some homology with the LPS-induced stimulation of murine B cells. The apparent lack of exogenous factor requirement for Ig synthesis, in this activation system, could be due to the endogenous production of B call differentiation factors by the irradiated CDw32 L cell transfectants and/or by the B cells themselves. In any case, the absence of secretion of Igs using downstream heavy chain genes by slgD + B cells in these culture conditions indicates that simultaneous triggering of CD40 and sIgs is not sufficient to induce Ig isotype switching. Additionally, it is noteworthy that SAC was consistently more potent than anti-IgM antibodies for stimulation of B call differentiation when combined with the anti-CD40 mAb. In the slgD-subset, antiIgM antibodies failed to cooperate with anti-CD40 for Ig synthesis in spite of the presence of sIgM § B cells which were inducible for IgM secretion by the combination of SAC and anti-CD40. One plausible explanation for this finding could be that the stimulatory effect of SAC resides in its capacity to trigger both slgs and MHC dass II molecules since Staphylococcal exotoxins have been described to stimulate B cell differentiation through binding to MHC class II antigens (41) .
In our hands, sIgD + B cells could secrete moderate amounts of IgA upon costimulation with an anti-CD40 mAb presented on CDw32 L cells and Ibl0. The frequency of IgAsecreting cells (<0.5%, on average) induced by Ibl0 is compatible with a level of contamination of sIgD § B cells with IgA-committed precursors which would fall beyond the threshold of detection of the flow-cytometry analysis. Therefore, considering that human and viral IL-10 are extremely potent B cell growth and differentiation factors (42), we cannot rule out the possibility that a minor contaminating population ofpostswitch B cells could account for the IL-10-mediated IgA synthesis by slgD + B cells. However, one of the major points which emerged from the present study was the observation that TGF-fl could stimulate IgA secretion from naive human B lymphocytes. Two lines of evidence argue in favor of the hypothesis that IgA isotype switching occurs in response to TGF-fl stimulation. First, it is well documented that TGF-fl inhibits both proliferation (43) and differentiation (44) of human B lymphocytes. Therefore, it is unlikely that its IgA-potentiating effect could result from outgrowth and maturation of a few slgA § contaminants. Second, in accordance with data previously reported in routine models (33), we observed that TGF-fl strongly suppressed IgA synthesis in the slgD-B cell subset thus excluding the possibility that IgA-committed precursors could constitute the target of the IgA-stimulatory effect of TGF-fl observed in the slgD + B cell population. In light of these findings, one could reconsider the effects of I1. In conclusion, we have developed an in vitro system, relying on the concomitant ligation of slgs and CD40, which allows T-independent differentiation of human B cells. This experimental model has permitted us to show that TGF-fl can stimulate IgA production from naive B cells, probably as a consequence of class switching. Our data indicate that crosslinking of CD40, but not of slgs, provides one of the obligatory signals required for induction of IgA synthesis by slgD + B cells in response to TGF-fl. The TGF-fl-dependent regulation of IgA isotype selection in humans appears to differ from the IL-4-dependent regulation of IgE dass switching. Indeed, whereas anti-CD40 antibodies and Ib4 are sufficient to induce commitment of human B cells to IgE secretion, combinations of anti-CD40 and TGF-fl consistently failed to elicit IgA synthesis from slgD + B cells. Therefore, we speculate that (a) IgA isotype switching occurs after costimulation of slgD + B cells with anti-CD40 and TGF-fl; and (b) the signal necessary for growth and differentiation of the newly IgA-committed B cells is lacking under these culture conditions, unless IIr is also provided. The notion that II.,10 could be involved in the final B cell maturation step is supported by the observation that Ibl0 can drive human B lymphocytes to a plasma-like stage of differentiation (F. Rousset et al., unpublished observations). Experiments are presently being carried out to test the validity of such a model.
